2/25
06:24 am
stok
Stoke Therapeutics (STOK) was upgraded by Wolfe Research to "strong-buy".
Low
Report
Stoke Therapeutics (STOK) was upgraded by Wolfe Research to "strong-buy".
2/25
06:24 am
stok
Stoke Therapeutics (STOK) was upgraded by Wolfe Research to "strong-buy".
Low
Report
Stoke Therapeutics (STOK) was upgraded by Wolfe Research to "strong-buy".
2/24
07:19 am
stok
Rating for STOK
Low
Report
Rating for STOK
2/24
07:19 am
stok
Rating for STOK
Low
Report
Rating for STOK
2/23
06:01 pm
stok
Stoke Therapeutics (NASDAQ:STOK) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Medium
Report
Stoke Therapeutics (NASDAQ:STOK) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
2/23
06:01 pm
stok
Stoke Therapeutics (NASDAQ:STOK) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Medium
Report
Stoke Therapeutics (NASDAQ:STOK) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
2/23
04:12 pm
stok
Stoke Therapeutics initiated with an Outperform at Wolfe Research
Low
Report
Stoke Therapeutics initiated with an Outperform at Wolfe Research
2/23
04:12 pm
stok
Stoke Therapeutics initiated with an Outperform at Wolfe Research
Low
Report
Stoke Therapeutics initiated with an Outperform at Wolfe Research
2/7
06:18 am
stok
Stoke Therapeutics (NASDAQ:STOK) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
Low
Report
Stoke Therapeutics (NASDAQ:STOK) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
2/7
06:18 am
stok
Stoke Therapeutics (NASDAQ:STOK) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
Low
Report
Stoke Therapeutics (NASDAQ:STOK) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
2/5
05:03 am
stok
Stoke Therapeutics (NASDAQ:STOK) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Medium
Report
Stoke Therapeutics (NASDAQ:STOK) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
2/5
05:03 am
stok
Stoke Therapeutics (NASDAQ:STOK) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Medium
Report
Stoke Therapeutics (NASDAQ:STOK) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
2/5
04:55 am
stok
Stoke Therapeutics initiated with a Buy at Guggenheim
Medium
Report
Stoke Therapeutics initiated with a Buy at Guggenheim
2/5
04:55 am
stok
Stoke Therapeutics initiated with a Buy at Guggenheim
Medium
Report
Stoke Therapeutics initiated with a Buy at Guggenheim
1/12
08:51 am
stok
Rating for STOK
Medium
Report
Rating for STOK
1/12
08:51 am
stok
Rating for STOK
Medium
Report
Rating for STOK
1/5
08:22 am
stok
Rating for STOK
Medium
Report
Rating for STOK
1/5
07:09 am
stok
Rating for STOK
Medium
Report
Rating for STOK